search
Back to results

Dexmedetomidine Infusion and Surgical Pleth Index In Pediatrics

Primary Purpose

Pain, Hypospadias

Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Dexmedetomidine
Lactated Ringer
Hypospadias
Surgical pleth index
Sponsored by
Fayoum University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pain focused on measuring Dexmedetomidine, Hypospadias, Postoperative analgesia, Surgical pleth index

Eligibility Criteria

1 Year - 7 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Age 1-7years. ASA physical status I-II. Hypospadias surgery. Exclusion Criteria: Children having a history of mental retardation. Developmental delay. Allergic to dexmedetomedine. Neuraxial anesthesia. Cardiovascular disease.

Sites / Locations

  • Fayoum University hospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Control group

Dexmedetomidine group

Arm Description

The control group, lactated ringer solution will be infused.

In the dexmedetomidine group, dexmedetomidine will be infused.

Outcomes

Primary Outcome Measures

Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus

Secondary Outcome Measures

Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Surgical pleth index number
from 0 to 100, higher values indicate strong surgical stimulus
Mean arterial blood pressure
in mmHg
Mean arterial blood pressure
in mmHg
Mean arterial blood pressure
in mmHg
Heart rate
beat/minute
Heart rate
beat/minute
Heart rate
beat/minute
Heart rate
beat/minute
Mean arterial blood pressure
mmHg
Need of vasoactive drugs
Yes or no
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Ramsay sedation score
0:5 with 0:deeply sedation to 5:no sedation
Ramsay sedation score
0:5 with 0:deeply sedation to 5:no sedation
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
FLACC pain score
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Surgical time
from when the surgeon of record starts the procedure until complete skin closure in minutes
Anesthesia time
from the start of anesthesia to the end of an anesthesia service in minutes
Total opioid consumption
in milligram
Time of 1st analgesia dose
time when first analgesic drug is injected for pain (in hours)
Total non-steroidal consumption
time when first usage of non-steroidal anti-inflammatory drug is injected for pain (in hours)
Extubation time
time from the end of surgery to airway extubation (in minutes)

Full Information

First Posted
January 24, 2023
Last Updated
February 13, 2023
Sponsor
Fayoum University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05727969
Brief Title
Dexmedetomidine Infusion and Surgical Pleth Index In Pediatrics
Official Title
Effect Of Dexmedetomidine Infusion On Surgical Pleth Index In Pediatrics Undergoing Hypospadias Repair; A Prospective Observational Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 15, 2023 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Fayoum University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart rate. SPI value is correlated to pain and ranges from 0 to 100, higher values indicate strong surgical stimulus. Its value is obtained from photoplethysmographic amplitude (PPGA) and heart rate (HR) data from pulse oximetry measurement. Prediction of the severity of postoperative pain using SPI in both adults and children has been reported by several studies. So, the authors hypothesize that dexmedetomidine infusion without giving a bolus dose may affect the SPI in pediatrics undergoing hypospadias repair.
Detailed Description
After obtaining Fayoum University's ethical committee permission and as well as the informed consent from the parents, 90 patients aged 1 to 7 years old scheduled for hypospadias repair will be randomly assigned into 2 groups. Preoperative Assessment: All patients will be assessed clinically and investigated for exclusion of any of the above-mentioned contraindications. Perioperative Management: Patients will receive no premedication. After entering the Operating room, All patients will be monitored using surgical pleth index, arterial blood pressure, pulse oximetry, and electrocardiography. The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system. Inhalational induction of general anesthesia (GA) will be performed with a face mask using sevoflurane 8% and 50% oxygen in the air, and then an intravenous (IV) cannula will be inserted. Fentanyl will be administered intravenously at 1 μg/kg, atracurium 0.5 mg/kg and an endotracheal tube will be used to secure the airway. Anesthesia will be maintained with 1% isoflurane, 50% oxygen in the air, and atracurium infusion (0.10 mg/kg). During the operation, bradycardia is defined as a 30% decrease from the baseline HR, and hypotension is defined as a 30% decrease from the baseline MAP. In these cases, 0.01 mg/kg of atropine and 0.1 mg/kg of ephedrine, respectively, will be given intravenously. Additionally, tachycardia is defined as a 30% increase from the baseline HR, and hypertension is defined as a 30% increase from the baseline MAP. If either of these occurred, 0.1 μg/kg of fentanyl was given intravenously, and then the incidence was calculated and analyzed. At the end of the surgery, acetaminophen 15 mg/kg IV will be administered to all patients. After completion of the surgical procedure and emergence from anesthesia, the patient will be referred to PACU. Quality of analgesia will be assessed using a face, legs, activity, cry, consolability (FLACC scale) at PACU discharge and 2, 4, 6, 12, and 24 hours postoperatively. Diclofenac sodium 1 mg/kg rectally will be given as rescue analgesia for patients in all study groups in PACU if the FLACC scale > 4. Nurses will be informed about the pain evaluation, to give the patients oral paracetamol 30 mg/kg. The data collectors from nurses will record data. The depth of sedation will be assessed using Ramsy sedation score (RSS) at PACU discharge and 2 hours postoperative by the investigators. The patient will be discharged from PACU using The Modified Aldrete Score system after an assessment of the patient's activity, respiration, blood pressure, consciousness, and color, A score ≥ 9 is required for discharge from the PACU. Adverse events like bradycardia hypotension excessive sedation respiratory depression postoperative agitation nausea and vomiting will be recorded during the first 24 hours. Statistical analysis Sample size calculation was done using IBM SPSS version 29 for Windows. A total of 45 children per group are needed to be able to detect an expected difference in the SPI based on previous research.This sample size was estimated using a power of 80% and alpha of 0.05. Descriptive statistics for the variables will be presented in the form of mean with standard deviation or median with interquartile range for numeric variables, while frequencies and percentages will be used for categorical variables. Comparison of the two groups will be done after testing for normality of the distribution using Shapiro-wilk test. The analysis will be done using the independent samples t test or using the non-parametric Mann Whitney test for numerical variables. Categorical variables will be compared using Chi Square test or Fisher's exact test. IBM SPSS version 28 for Windows software will be used for the analysis. A p-value of < 0.05 will be considered statistically significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Hypospadias
Keywords
Dexmedetomidine, Hypospadias, Postoperative analgesia, Surgical pleth index

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The randomization will be computer generated random number and the randomization sequence will be kept hidden in sealed opaque envelopes just opened after recruitment and admittance to the operating room.
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
The group's allocations will be only blinded to assessors, data collectors, and parents of children
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
Placebo Comparator
Arm Description
The control group, lactated ringer solution will be infused.
Arm Title
Dexmedetomidine group
Arm Type
Experimental
Arm Description
In the dexmedetomidine group, dexmedetomidine will be infused.
Intervention Type
Drug
Intervention Name(s)
Dexmedetomidine
Other Intervention Name(s)
Precedex
Intervention Description
Dexmedetomidine at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.
Intervention Type
Drug
Intervention Name(s)
Lactated Ringer
Other Intervention Name(s)
Solution
Intervention Description
Lactated ringer solution at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.
Intervention Type
Procedure
Intervention Name(s)
Hypospadias
Other Intervention Name(s)
pediatric manuvere
Intervention Description
Children who will undergone hypospadias surgery
Intervention Type
Device
Intervention Name(s)
Surgical pleth index
Other Intervention Name(s)
SPI
Intervention Description
The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.
Primary Outcome Measure Information:
Title
Surgical pleth index number
Description
from 0 to 100, higher values indicate strong surgical stimulus
Time Frame
1 minute at end of the operation after skin closure.
Secondary Outcome Measure Information:
Title
Surgical pleth index number
Description
from 0 to 100, higher values indicate strong surgical stimulus
Time Frame
1 minute before induction of anesthesia.
Title
Surgical pleth index number
Description
from 0 to 100, higher values indicate strong surgical stimulus
Time Frame
1 minute after insertion of endotracheal tube.
Title
Surgical pleth index number
Description
from 0 to 100, higher values indicate strong surgical stimulus
Time Frame
1 minute after beginning of surgery with skin incision.
Title
Surgical pleth index number
Description
from 0 to 100, higher values indicate strong surgical stimulus
Time Frame
5 minutes after recovery at post anesthesia care unit.
Title
Mean arterial blood pressure
Description
in mmHg
Time Frame
5 minutes after recovery at post anesthesia care unit.
Title
Mean arterial blood pressure
Description
in mmHg
Time Frame
1 minute before induction of anesthesia.
Title
Mean arterial blood pressure
Description
in mmHg
Time Frame
1 minute after beginning of surgery with skin incision.
Title
Heart rate
Description
beat/minute
Time Frame
1 minute after beginning of surgery with skin incision.
Title
Heart rate
Description
beat/minute
Time Frame
1 minute before induction of anesthesia.
Title
Heart rate
Description
beat/minute
Time Frame
5 minutes after recovery at post anesthesia care unit.
Title
Heart rate
Description
beat/minute
Time Frame
1 minute at end of the operation after skin closure.
Title
Mean arterial blood pressure
Description
mmHg
Time Frame
1 minute at end of the operation after skin closure.
Title
Need of vasoactive drugs
Description
Yes or no
Time Frame
1minute after infusion until end of surgery
Title
FLACC pain score
Description
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Time Frame
5 minutes after recovery in postanesthesia care unit
Title
FLACC pain score
Description
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Time Frame
2 hours after recovery in postanesthesia care unit
Title
Ramsay sedation score
Description
0:5 with 0:deeply sedation to 5:no sedation
Time Frame
5 minutes after recovery in postanesthesia care unit
Title
Ramsay sedation score
Description
0:5 with 0:deeply sedation to 5:no sedation
Time Frame
2 hours after recovery in postanesthesia care unit
Title
FLACC pain score
Description
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Time Frame
4 hours after discharge from recovery
Title
FLACC pain score
Description
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Time Frame
6 hours after discharge from recovery
Title
FLACC pain score
Description
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Time Frame
12 hours after discharge from recovery
Title
FLACC pain score
Description
F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children
Time Frame
24 hours after discharge from recovery
Title
Surgical time
Description
from when the surgeon of record starts the procedure until complete skin closure in minutes
Time Frame
1 minute after skin
Title
Anesthesia time
Description
from the start of anesthesia to the end of an anesthesia service in minutes
Time Frame
5 minutes after insertion of endotracheal tube
Title
Total opioid consumption
Description
in milligram
Time Frame
24 hours after operation
Title
Time of 1st analgesia dose
Description
time when first analgesic drug is injected for pain (in hours)
Time Frame
24 hours postoperatively
Title
Total non-steroidal consumption
Description
time when first usage of non-steroidal anti-inflammatory drug is injected for pain (in hours)
Time Frame
24 hours postoperatively
Title
Extubation time
Description
time from the end of surgery to airway extubation (in minutes)
Time Frame
2 minutes after removal of endotracheal tube
Other Pre-specified Outcome Measures:
Title
Age
Description
in years
Time Frame
1 hour preoperatively
Title
American society of anesthesiology classification
Description
Either I: normal healthy or II: mild systemic disease
Time Frame
1 hour preoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 1-7years. ASA physical status I-II. Hypospadias surgery. Exclusion Criteria: Children having a history of mental retardation. Developmental delay. Allergic to dexmedetomedine. Neuraxial anesthesia. Cardiovascular disease.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mohamed A Hamed, MD
Phone
01010509736
Ext
+2
Email
mah07@fayoum.edu.eg
First Name & Middle Initial & Last Name or Official Title & Degree
Emad M Abdelfatah, MBBCh
Phone
01094006418
Ext
+2
Email
omado.hos@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Safaa G Megahed, MD
Organizational Affiliation
Fayoum University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Omar S Mahmoud, MD
Organizational Affiliation
Fayoum University
Official's Role
Study Director
Facility Information:
Facility Name
Fayoum University hospital
City
Madīnat al Fayyūm
State/Province
Faiyum Governorate
ZIP/Postal Code
63514
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mohamed A Hamed, MD.
Phone
010105093736
Ext
+20
Email
mah07@fayoum.edu.eg
First Name & Middle Initial & Last Name & Degree
Yasser S Mostafa, M.D.
Phone
1010509735
Ext
+20
Email
ysm03@fayoum.edu.eg

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
17329347
Citation
Huiku M, Uutela K, van Gils M, Korhonen I, Kymalainen M, Merilainen P, Paloheimo M, Rantanen M, Takala P, Viertio-Oja H, Yli-Hankala A. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007 Apr;98(4):447-55. doi: 10.1093/bja/aem004. Epub 2007 Feb 28.
Results Reference
background
PubMed Identifier
22369767
Citation
Hamunen K, Kontinen V, Hakala E, Talke P, Paloheimo M, Kalso E. Effect of pain on autonomic nervous system indices derived from photoplethysmography in healthy volunteers. Br J Anaesth. 2012 May;108(5):838-44. doi: 10.1093/bja/aes001. Epub 2012 Feb 26.
Results Reference
background
PubMed Identifier
25410376
Citation
Constant I, Sabourdin N. Monitoring depth of anesthesia: from consciousness to nociception. A window on subcortical brain activity. Paediatr Anaesth. 2015 Jan;25(1):73-82. doi: 10.1111/pan.12586. Epub 2014 Nov 20.
Results Reference
background

Learn more about this trial

Dexmedetomidine Infusion and Surgical Pleth Index In Pediatrics

We'll reach out to this number within 24 hrs